TGFB and related signalling components are overexpressed in CLL, follicular lymphoma (FL), hairy cell leukaemia (HCL), and mantle cell lymphoma (MCL), as well as multiple myeloma (MM) [81,82,83,84,85,86,87,88,89,90]. Here, TGFB1 is linked to plasma cell myeloma.